Company / Cash per Share
Syndax Pharmaceuticals Inc Cash per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash per Share
$1.57
FY2025
5-year range
$1.35 / $4.34
FY2021-FY2025
Trend
-13.3%
vs FY2024
Sector context
#122 of 205
Health Care
What the data says
At $1.57, Syndax Pharmaceuticals Inc's cash per share ranks #122 of 205 in the Health Care sector. Cash per Share has fluctuated over the past 10 years, ranging from $0.91 in FY2020 to $117.15 in FY2016.
Based on SEC 10-K filings.
1.57 in FY2025 with a 5-year CAGR of +11.7%.
Declined from $4.34 to $1.57 over the past 2 years.
Health Care sector context is included.
Cash per Share over time
Growth rates
- 3-Year CAGR
- +5.2%
- 5-Year CAGR
- +11.7%
- 10-Year CAGR
- -
Sector benchmark
#122 of 205 in Health CareTop 60% of 205This company $1.57 Sector average $72.93
▼
-97.8% below sector average
Key checks
Key Insights
- In FY2025, cash per share decreased 13.3% year-over-year.
- Ranks #122 out of 205 companies in the Health Care sector.
- Peak cash per share was recorded in FY2016.
- Lowest cash per share in the period was in FY2020.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -3.08 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.57 | -13.3% |
| FY2024 | $1.82 | -58.1% |
| FY2023 | $4.34 | +220.7% |
| FY2022 | $1.35 | -43.8% |
| FY2021 | $2.41 | +165.4% |
| FY2020 | $0.91 | -33.3% |
| FY2019 | $1.36 | -5.7% |
| FY2018 | $1.44 | +10.2% |
| FY2017 | $1.31 | -98.9% |
| FY2016 | $117.15 | -65.5% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026